• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心碎何时最危险?评估预测应激性心肌病住院患者死亡的风险因素:对2021年全国住院患者样本的分析。

When Is the Broken Heart Most Dangerous? Assessing Risk Factors to Predict Inpatient Death in Takotsubo Cardiomyopathy: Analysis of the National Inpatient Sample for 2021.

作者信息

Ogunniyi Kayode Emmanuel, Akinmoju Olumide Damilola, Olatunji Gbolahan, Kokori Emmanuel, Aderinto Nicholas, Ogieuhi Ikponmwosa Jude, Akingbola Adewunmi, Bisola Muhammadul-Awwal Irodatullah, Ajimotokan Oluwafemi Isaiah, Ajala Peace, Padda Inderbir, Mahtani Arun U, Awoyemi Toluwalase, Nfonoyim Jay

机构信息

Richmond University Medical Center/Mount Sinai Staten Island NY USA.

Montefiore St. Luke's Cornwall Newburgh NY USA.

出版信息

J Am Heart Assoc. 2025 Aug 5;14(15):e040167. doi: 10.1161/JAHA.124.040167. Epub 2025 Jul 17.

DOI:10.1161/JAHA.124.040167
PMID:40673530
Abstract

BACKGROUND

Takotsubo cardiomyopathy (TC) has a similar clinical presentation to acute coronary syndromes (ACS). As the prevalence and influence on clinical decisions of this condition are being increasingly recognized, prognostic factors have yet to be established. We applied known near-term acute coronary syndrome mortality risk factors to determine their prognostic value in TC. This study aimed to assess the patient characteristics and comorbidities predicting inpatient death from TC. Understanding these risk factors is essential for clinical decision making and improving prognostic assessments.

METHODS

We analyzed the National Inpatient Sample database for 2021. Inclusion criteria were principal diagnosis of TC (, [] code I51.81) and age ≥18 years. Different comorbidities, age, and sex were analyzed, and the primary outcome was inpatient death. Univariate logistic regression was used to test the association of each factor with death, and multivariate logistic regression was then used to test for independent predictive value.

RESULTS

A total of 9109 admissions for TC were identified (10.3% men and 89.7% women) with a mean age of 67 years and an inpatient mortality rate of 2.31%. On univariate regression, age (odds ratio [OR], 1.04; =0.013), heart failure (OR, 3.2; <0.001), atrial fibrillation (OR, 3.12; <0.001), and chronic kidney disease (OR, 3.54; <0.001) were significant predictors of inpatient death. On multivariate regression, only heart failure (OR, 2.8; =0.007) and chronic kidney disease (OR, 2.34; =0.032) were independently associated with inpatient death.

CONCLUSIONS

Preexisting heart failure and a history of chronic kidney disease are poor prognostic factors in patients presenting with TC. Further large-scale studies are required to validate our findings.

摘要

背景

应激性心肌病(TC)的临床表现与急性冠状动脉综合征(ACS)相似。随着这种疾病的患病率及其对临床决策的影响日益受到认可,其预后因素尚未确定。我们应用已知的近期急性冠状动脉综合征死亡风险因素来确定它们在TC中的预后价值。本研究旨在评估预测TC住院患者死亡的患者特征和合并症。了解这些风险因素对于临床决策和改善预后评估至关重要。

方法

我们分析了2021年的全国住院患者样本数据库。纳入标准为TC的主要诊断(国际疾病分类第十版[ICD-10]编码I51.81)且年龄≥18岁。分析了不同的合并症、年龄和性别,主要结局为住院死亡。单因素逻辑回归用于检验每个因素与死亡的关联,然后多因素逻辑回归用于检验独立预测价值。

结果

共确定了9109例TC住院病例(男性占10.3%,女性占89.7%),平均年龄67岁,住院死亡率为2.31%。在单因素回归中,年龄(比值比[OR],1.04;P = 0.013)、心力衰竭(OR,3.2;P < 0.001)、心房颤动(OR,3.12;P < 0.001)和慢性肾脏病(OR,3.54;P < 0.001)是住院死亡的显著预测因素。在多因素回归中,只有心力衰竭(OR,2.8;P = 0.007)和慢性肾脏病(OR,2.34;P = 0.032)与住院死亡独立相关。

结论

既往存在心力衰竭和慢性肾脏病病史是TC患者预后不良的因素。需要进一步的大规模研究来验证我们的发现。

相似文献

1
When Is the Broken Heart Most Dangerous? Assessing Risk Factors to Predict Inpatient Death in Takotsubo Cardiomyopathy: Analysis of the National Inpatient Sample for 2021.心碎何时最危险?评估预测应激性心肌病住院患者死亡的风险因素:对2021年全国住院患者样本的分析。
J Am Heart Assoc. 2025 Aug 5;14(15):e040167. doi: 10.1161/JAHA.124.040167. Epub 2025 Jul 17.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Consequences, costs and cost-effectiveness of workforce configurations in English acute hospitals.英国急症医院劳动力配置的后果、成本及成本效益
Health Soc Care Deliv Res. 2025 Jul;13(25):1-107. doi: 10.3310/ZBAR9152.
4
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
Prognostic implications of takotsubo cardiomyopathy in cardiogenic shock: A propensity score-matched analysis of the national inpatient sample (2016-2020).Takotsubo心肌病在心源性休克中的预后影响:对全国住院患者样本(2016 - 2020年)的倾向评分匹配分析
Heart Lung. 2025 Sep-Oct;73:162-169. doi: 10.1016/j.hrtlng.2025.05.004. Epub 2025 May 24.
7
High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy With More Than Double Mortality in Men Without Improvement in Outcome Over the Years.Takotsubo心肌病患者的高死亡率和并发症,男性死亡率超过两倍,多年来预后无改善。
J Am Heart Assoc. 2025 May 20;14(10):e037219. doi: 10.1161/JAHA.124.037219. Epub 2025 May 14.
8
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.